Globus Medical Director Files Intent to Sell $2.1M in Stock (GMED)
GLOBUS MEDICAL INC
Subscribe to track GMED
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Globus Medical Director Files Intent to Sell $2.1M in Stock (GMED)
Company: GLOBUS MEDICAL INC (GMED) Form: 144 | Filed: 2025-11-12 Significance: Low
Insider: ZARRILLI STEPHEN T Title: null | Relationship: Director
Transaction: • Type: Proposed Sale • Shares: 25,000 • Price: ~$84.24 • Value: $2,106,000 • Owned After: Not Disclosed
Key Insight: A director has filed a notice of intent to sell 25,000 shares, a transaction representing a negligible fraction (0.018%) of the company's market cap.
Market Context: The proposed sale is small relative to Globus Medical's $11.56B market capitalization and is unlikely to have a material impact on the stock.
Comprehensive Analysis
SEC Filing Analysis: GLOBUS MEDICAL INC (GMED)
Executive Summary
- Trading Significance: Low
- Key Takeaway: A director at Globus Medical has filed a Form 144, signaling an intent to sell $2.1 million worth of common stock.
- Market Impact: The transaction is of low materiality and is not expected to impact the stock price due to its small size relative to the company's market cap and trading volume.
Company Information
| Field | Value |
|---|---|
| Company | GLOBUS MEDICAL INC |
| Ticker Symbol | GMED |
| CIK | 0001237831 |
| Industry | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] |
Insider Information
| Field | Value |
|---|---|
| Name | ZARRILLI STEPHEN T |
| CIK | 0001203410 |
| Title/Position | null |
| Relationship | Director |
Transaction Details
| Field | Value |
|---|---|
| Form Type | 144 |
| Transaction Date | 2025-11-11 |
| Transaction Code | S |
| Security Type | Common |
| Shares Involved | 25,000 |
| Price Per Share | $84.24 |
| Total Value | $2,106,000 |
| Shares Owned After | null |
| Ownership Type | null |
Financial Impact Assessment
Transaction Materiality
| Metric | Value |
|---|---|
| Transaction Value | $2,106,000 |
| % of Market Cap | 0.018% |
| Shares Transacted | 25,000 |
| % of Shares Outstanding | 0.019% |
| Post-Transaction Ownership | Not Disclosed |
| Materiality Assessment | Low |
Impact Evaluation
- Market Cap Context: For a large-cap company like Globus Medical ($11.56B market cap), a $2.1M sale is considered routine and financially immaterial.
- Transaction Significance: The proposed sale is of low significance. It does not meet the thresholds for moderate, significant, or highly significant impact based on either value or share volume, representing less than 0.02% of both market cap and shares outstanding.
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: The sale is very small (<0.02% of market cap) and represents a routine transaction for an insider at a large-cap company. It does not signal a change in the insider's outlook on the company.
Volume & Sentiment
- Expected Volume Impact: Minimal. The transaction size is unlikely to be noticeable against the stock's average daily trading volume.
- Sentiment Indicator: Neutral.
Additional Context
Transaction Notes
- Source: The filing indicates the shares were acquired via a cashless stock option exercise, and this Form 144 represents the notice of intent to sell those shares.
- Filing Type: Form 144 is a notice of proposed sale, not a confirmation of a completed trade. The sale is expected to occur on or around the approximate sale date.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.